Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to Meta Platforms Inc. and Google LLC in violation of state and federal privacy ...

Abbott Laboratories recently received FDA approval for its redesigned CardioMEMS Hero remote heart failure monitoring system, featuring a smaller, lighter reader aimed at improving patient convenience ...

Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s ...

Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking one of the biggest offerings this year.

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...

Add Yahoo as a preferred source to see more of our stories on Google. A federal judge has thrown out a second case against Abbott Laboratories over the safety of its formula for babies born ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over ...

Abbott Laboratories sold $20 billion of bonds to help fund its acquisition of cancer-screening company Exact Sciences Corp. on Monday, one of the US high-grade market’s biggest offerings this year.

The stock's fall snapped a three-day winning streak.